SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $49,960,187 |
| Positions | 5 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | PRAX | COM NEW | $22,073,709 | 65,933 |
| ALTO NEUROSCIENCE INC | ANRO | COM SHS | $17,622,661 | 667,778 |
| LENZ THERAPEUTICS INC | LENZ | COM | $5,780,826 | 1,017,751 |
| KORRO BIO INC | KRRO | COM | $3,648,633 | 276,831 |
| CARIBOU BIOSCIENCES INC | CRBU | COM | $834,358 | 474,067 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.